Join the 'Cancer' group to help and get support from people like you.

Cancer Blog

Related terms: Carcinoma, Malignant Disease, Malignant Tumor

Parents of Child Cancer Patients Prefer Honesty, Study Finds

Posted 9 days ago by Drugs.com

MONDAY, May 18, 2015 – It's better for doctors to be open with parents about their child's cancer prognosis, even if the news is bad, researchers say. Doing so is more likely to give parents peace of mind and hope rather than increase their anxiety or cause them to become despondent, the study found. "Providing families with a full explanation of the likely course of a disease is critical to helping them plan and have reasonable expectations about the outcome of treatment," said study leader Dr. Jonathan Marron, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Researchers asked 353 parents of children newly diagnosed with cancer about their discussions with their child's doctors and whether those conversations had a negative or positive effect. Among parents of children with poorer prognoses, those who received an honest appraisal said they gained peace of mind and ... Read more

Related support groups: Cancer, Diagnosis and Investigation

Health Tip: Coping With Diarrhea From Chemo

Posted 12 days ago by Drugs.com

-- Chemotherapy treatment can lead to a host of digestive problems, including diarrhea. The Academy of Nutrition and Dietetics suggests: Eat smaller meals more frequently. To replace the salt you've lost, snack on small amounts of pretzels or crackers. Sip on a non-caffeinated beverage throughout the day. Drink juices that are lower in acid, such as pear, apricot or peach nectar. Drink fluids between meals, instead of with them. Read more

Related support groups: Cancer, Diarrhea

HPV Vaccination for Girls May Help Prevent Cancers in Males

Posted 15 days ago by Drugs.com

TUESDAY, May 12, 2015 – Males benefit indirectly when girls are immunized against the sexually transmitted human papillomavirus (HPV), according to a new Dutch study. However, males still have a risk of developing HPV-related cancers, the study authors said. And while giving the vaccine to boys would further reduce the burden of later HPV infection in men, it may not be cost-effective because hundreds of boys would need to be vaccinated to prevent one case of cancer from HPV, the researchers found. The findings provide more insight as countries around the world try to figure out how widely to distribute the HPV vaccine, which was initially developed to prevent cervical cancer in women caused by HPV. The study shows that "it's a complicated situation," said Karen Canfell, director of cancer research with Cancer Council NSW in Sydney, Australia. Canfell, who wrote a commentary ... Read more

Related support groups: Cancer, Colorectal Cancer, Cervical Cancer, Human Papilloma Virus, Head and Neck Cancer, Cervical Dysplasia, Human Papillomavirus Prophylaxis

'Wiser' Surgeries for Those With Terminal Cancers

Posted 16 days ago by Drugs.com

MONDAY, May 11, 2015 – While surgery rates for patients with late-stage, terminal cancers have stayed about the same in recent years, complications and deaths for these patients have fallen because surgeons are more selective about who has surgery, a new study finds. "Surgeons are becoming wiser," study author Dr. Sarah Bateni, a surgery resident at the University of California, Davis, said in a university news release. "Our research suggests that surgeons may be operating on healthier patients who are more likely to recover well from an operation," she said. "These are patients who can perform activities of daily living without assistance, for example." As Bateni explained, there are a number of reasons why surgeons might operate on late-stage cancer patients. "Some of it has to do with the patients and families," she said. "If the patient is uncomfortable, the family wants a ... Read more

Related support groups: Surgery, Cancer, Colorectal Cancer, Head & Neck Surgery, Neurosurgery, Surgical Prophylaxis, Gastrointestinal Surgery, Cardiothoracic Surgery, Solid Tumors, Biliary Tract Surgery

They Overcame Childhood Cancer, But Now Obesity?

Posted 16 days ago by Drugs.com

MONDAY, May 11, 2015 – Certain treatments may increase a childhood cancer survivor's risk of obesity later in life, a new study says. "The ability to identify patients at increased risk may guide selection of therapeutic protocols that will maximize treatment outcomes while simultaneously minimizing the risk of long-term complications among children diagnosed with cancer," said study co-leader Kirsten Ness, of St. Jude Children's Research Hospital in Memphis. The researchers looked at nearly 2,000 people who'd been diagnosed with childhood cancer at least 10 years earlier. They found that almost half who underwent cranial radiation were obese. This compared with just over 29 percent of those who did not receive that type of treatment. Cranial radiation is used to prevent or delay the spread of cancer to the brain. The risk of obesity among survivors treated with cranial radiation was ... Read more

Related support groups: Obesity, Cancer, Prednisone, Methylprednisolone, Prednisolone, Cortisone, Medrol, Hydrocortisone, Dexamethasone, Triamcinolone, Betamethasone, Budesonide, Decadron, Entocort, Solu-Medrol, Cortef, Celestone, Entocort EC, Medrol Dosepak, Depo-Medrol

Study Sees Improving Survival Odds for Ovarian Cancer

Posted 20 days ago by Drugs.com

THURSDAY, May 7, 2015 – Women diagnosed with ovarian cancer, traditionally viewed as an aggressive killer, are much more likely to survive the disease than they were several decades ago, new research shows. "Ovarian cancer, unfortunately, is associated with a very high death rate," said study author Dr. Jason Wright, a professor of obstetrics and gynecology at Columbia University College of Physicians and Surgeons in New York City. But that seems to be changing, he said. "We wanted to do this study because there have been a number of advances in the treatment of ovarian cancer," Wright said. "There is better surgery, better chemo and better ways to deliver the chemo. More recently, there has also been a better understanding of the biology and genetics of the cancer." To see if these advances have made an impact on survival rates, Wright's team evaluated nearly 50,000 women who were ... Read more

Related support groups: Cancer, Ovarian Cancer

Many Americans Not Getting Routine Cancer Screenings: CDC

Posted 7 May 2015 by Drugs.com

THURSDAY, May 7, 2015 – Many Americans aren't getting recommended screening tests for colon, breast and cervical cancers, a new federal study shows. Among adults in the age groups recommended for screening, about two in five were not up to date with colon cancer screening, one in four women were not up to date with breast cancer screening, and one in five women were not up to date with cervical cancer screening. In 2013, colon cancer screening rates were unchanged from 2010, the investigators found. In addition, cervical cancer screening using the Pap test in women aged 21 to 65 was lower than in 2000, and mammography screenings for breast cancer showed little change from previous years. One expert offered some theories on the disappointing screening rates. "It is often difficult to get patients to comply with screening tests, especially when they are uninsured or underinsured," said ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Prevention, Diagnosis and Investigation, Body Imaging, History - Skin Cancer

Healthy Lifestyle May Boost Colon Cancer Survival

Posted 7 May 2015 by Drugs.com

THURSDAY, May 7, 2015 – Colon cancer patients seem to have a better chance of survival if they have already been practicing healthy lifestyle habits before their diagnosis, a new study suggests. Survival rates for colon cancer vary widely, even among patients who have similar tumors and receive the same treatment. It has been suggested that lifestyle factors before and after colon cancer diagnosis play a role, according to the study authors. The new research supports the idea that the healthier a person's lifestyle score prior to diagnosis, the better the odds of survival. However, it should be noted that the study was only designed to show an association between healthy lifestyle factors and improved survival; it did not prove that these factors directly caused the better survival outcomes. The study included data from more than 520,000 people in 10 European countries. Their health ... Read more

Related support groups: Cancer, Colorectal Cancer

Nursing Homes Using Hospice Care More, But at a Cost

Posted 6 May 2015 by Drugs.com

WEDNESDAY, May 6, 2015 – More nursing home residents are opting for hospice care as they near death, choosing comfort and reassurance over medical interventions aimed at squeezing out every possible extra day of life. But while hospice care has proven effective in providing peace to the dying, it's also more expensive than previously thought, according to a new study published in the May 7 New England Journal of Medicine. Medicare costs for nursing home residents receiving hospice care increased an average of almost $6,800 per patient between 2004 and 2009, said study lead author Pedro Gozalo, a research associate professor of health services, policy and practice at Brown University School of Public Health in Providence, R.I. This runs counter to the idea that hospice should cost less than traditional care because doctors aren't using expensive procedures to prolong life, Gozalo said. ... Read more

Related support groups: Cancer, Breast Cancer - Palliative

Little Risk of Vitamin D Toxicity, Study Says

Posted 6 May 2015 by Drugs.com

WEDNESDAY, May 6, 2015 – The risk for developing vitamin D toxicity is rare, researchers have found. With vitamin D supplementation on the rise, investigators set out to assess the odds of developing dangerously high blood calcium levels. "The evidence is clear that vitamin D toxicity is one of the rarest medical conditions and is typically due to intentional or inadvertent intake of extremely high doses," Dr. Michael Holick wrote in an editorial in the May issue of the Mayo Clinic Proceedings. Holick, of Boston University School of Medicine, was not involved in the study. Vitamin D is often recommended to improve or protect bone health, and there are indications it may also help prevent cancer, diabetes, and/or heart disease, the researchers noted. Apart from supplements, natural sources of vitamin D include oily fish (mackerel and salmon), fortified milk, and sunlight. The upper ... Read more

Related support groups: Diabetes, Type 2, Cancer, Heart Disease, Osteoporosis, Fracture, bone, Prevention of Osteoporosis, Caltrate 600 with D, Hypercalcemia, Calcium/Vitamin D, Os-Cal 500 with D, Citracal + D, Oysco 500 with D, Oyster Shell Calcium, Calcium 600 D, Citracal Creamy Bites, Calcet, Calcarb with D, Oyst-Cal-D, Os-Cal 500 + D, Oystercal-D

FDA Medwatch Alert: Adrucil (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL): Recall - Particulate Matter

Posted 5 May 2015 by Drugs.com

ISSUE: Teva Parenteral Medicines issued a voluntary recall of eight lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals. See the press release for a listing of affected lot numbers. Administration of an intravenous product with particulate matter has the potential to result in inflammation, allergic reactions, or blockage of blood vessels, leading to tissue death, which may be life-threatening if vital organs are affected. BACKGROUND: Adrucil Injection is used in the palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas and is packaged in pharmacy bulk packages. The pharmacy bulk package has five 5 g/100ml vials per shelf pack. Individual Adrucil 5 g/100 ml vials have the NDC code ... Read more

Related support groups: Cancer, Fluorouracil, Adrucil

Age-Linked Structures on DNA May Also Hint at Cancer Risk

Posted 5 May 2015 by Drugs.com

TUESDAY, May 5, 2015 – For the first time, researchers have identified a pattern of change in DNA that may signal the development of cancer long before a standard diagnosis can be made. At issue is the shifting status of telomeres in the blood. Study investigators describe telomeres as protective "caps" on the end of DNA strands. Telomeres have long been viewed as an important indicator of biological age because as people get older telomeres become shorter. The current study revealed that telomeres start to age at a faster pace than normal in people who eventually develop cancer. The study authors said that telomeres belonging to future cancer patients may shorten in length to such a degree that they resemble telomeres belonging to people 15 years older. "Understanding this pattern of telomere growth may mean it can be a predictive biomarker for cancer," study lead author Dr. Lifang ... Read more

Related support groups: Cancer, Diagnosis and Investigation

U.S. Hispanics Face Unique Health Challenges, CDC Says

Posted 5 May 2015 by Drugs.com

TUESDAY, May 5, 2015 – Hispanics in the United States carry very different health risks than whites and face a tougher time getting needed medical care, according to a new federal report. Similar to whites, the two leading causes of death among Hispanics are heart disease and cancer, the U.S. Centers for Disease Control and Prevention found in its first national study of Hispanic health issues. But Hispanics are much more likely than whites to die from diabetes, homicide, or chronic liver disease and cirrhosis, the CDC researchers found. They also are more likely to be obese. The good news is that Hispanics have an overall 24 percent lower death rate than whites, as well as lower death rates for nine of the 15 leading causes of death. These include cancer, heart disease, injuries, stroke, respiratory disease, Alzheimer's disease and suicide. This phenomenon is known as the "Hispanic ... Read more

Related support groups: Obesity, Cancer, Heart Disease, Cirrhosis, Liver Cirrhosis, Diabetes Mellitus, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter

Posted 25 Apr 2015 by Drugs.com

including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot numbers affected by this recall. Some products may be packaged with a Pfizer Injectables label (see Background below)   [Posted 04/24/2015] ISSUE: Mylan N.V. is conducting a voluntary nationwide recall to the hospital/user level of select lots of injectable products due to the presence of visible foreign particulate matter observed during testing of retention samples. Administration of a sterile injectable that has foreign particulates has the potential of severe health consequences. Intrathecal administration could result in a life threatening adverse event or result in permanent impairment of a body function. Intravenous administration has the potential to damage and/or obstruct blood ... Read more

Related support groups: Cancer, Methotrexate, Carboplatin, Gemzar, Gemcitabine, Cytarabine, Cytosar, Methotrexate LPF Sodium, Trexall, Cytosar-U, Paraplatin, Otrexup, Tarabine PFS, Folex PFS, Rheumatrex Dose Pack, Rasuvo, Carboplatin Novaplus

FDA Approves Cyramza (Ramucirumab) for Use with FOLFIRI in Second-Line Treatment of Metastatic Colorectal Cancer

Posted 24 Apr 2015 by Drugs.com

INDIANAPOLIS, April 24, 2015 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Cyramza (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine. "Cyramza now has approvals in advanced or metastatic forms of three of the world's most common and deadly cancers – gastric, non-small cell lung, and colorectal – with four FDA approvals received in just over a year," said Sue Mahony, Ph.D., senior vice president and president, Lilly Oncology. "This progress is encouraging and supports our ongoing development program for Cyramza. ... Read more

Related support groups: Cancer, Colorectal Cancer, Cyramza, Ramucirumab

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Renal Cell Carcinoma, Pancreatic Cancer, Bladder Cancer, Skin Cancer, Brain Tumor, view more... Cervical Cancer, Endometrial Cancer, Hypercalcemia of Malignancy, Soft Tissue Sarcoma, Head and Neck Cancer, Stomach Cancer, Testicular Cancer, Gastric Cancer, Solid Tumors, Urinary Tract Tumors, Lung Cancer, Malignant Pleural Mesothelioma, Osteosarcoma, Adrenal Cortical Carcinoma, Neuroendocrine Carcinoma, Ewing's Sarcoma, Malignant Pleural Effusion, Choriocarcinoma, Multicentric Castleman’s Disease, Peritoneal Cancer, Fallopian Tube Cancer, Urinary Tract Cancer

Related Drug Support Groups

fluorouracil, carboplatin, Cytoxan, cyclophosphamide, Leukeran, vincristine, Adriamycin, doxorubicin, vinblastine, view more... Mustargen, topotecan, chaparral, amifostine, fludarabine, etoposide, chlorambucil, Velban, Hycamtin, Fludara, Oncovin, thiotepa, ifosfamide, Cytoxan Lyophilized, Adrucil, Vincasar PFS, Tepadina, Ergamisol, Adriamycin PFS, Thioplex, Adriamycin RDF, Carboplatin Novaplus, Cosmegen, Ethyol, mechlorethamine, levamisole, dactinomycin, Paraplatin, Neosar, Toposar, Etopophos, VePesid, Ifex